Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes
NHS hospitals in England used £20,080,278 of indicative cost of Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 22.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| B'ham & S'hull Mh Nhs Foundation Trust | £1,133,566 |
| Cheshire & Wirral P/S Nhs Foundation Tr | £1,073,756 |
| South London & Maudsley Nhs Found Trust | £949,784 |
| Sussex Partnership Nhs Foundation Trust | £896,805 |
| Ctrl & N W London Nhs Foundation Trust | £888,558 |
| East London Nhs Foundation Trust | £884,218 |
| Essex Partnership University Nhs Ft | £834,747 |
| North London Nhs Foundation Trust | £828,892 |
| Nottinghamshire Healthcare Nhs F Trust | £736,976 |
| Avon & Wiltshire Mental Hlth P/Ship Trst | £719,702 |
The primary-care picture
Paliperidone is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Paliperidone medicine page.